Stock analysis · Bull Rankings model

XRAY analysis

DENTSPLY SIRONA IncHealth Care. Scored on the same transparent 7-signal model behind the daily rankings.

XRAY
DENTSPLY SIRONA Inc · Health Care
FCF$104mC
Rev-1.0%D+
D/E1.74C
P/S0.6xA
PEG
66Score
$9.99
1Y Target$13.49Near-term target
5Y Target$20.09Compound horizon
10Y Target$52.29Long-dated conviction
FCF$104mTTM · 03/26
C
FCF $104m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev-1.0%TTM YoY
D+
Revenue -1.0% — shrinking; needs a catalyst to reverse · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E1.74total
C
D/E 1.74 — elevated leverage, limits flexibility · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S0.6x
A
P/S 0.6x — deep value on sales
PEGproxy
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $2.0b. Down 42% from 52-week high of $17.09 — deep drawdown territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -17.1%) — path to GAAP profitability is the core thesis risk. Down 42% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. ROE -41% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $13.49 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $20.09 — requires the platform / technology to reach commercial scale. 10 yr $52.29 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Shares to buy
200
Position size
$1,998
4.0% of portfolio
Stop price
$7.49
25% below $9.99
$ at risk
$500.00
1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Analyze another ticker →